Wikiwand AI

25TFM-NBOMe

Chemical compound From Wikipedia, the free encyclopedia

25TFM-NBOMe (also known as NBOMe-2C-TFM, 2C-TFM-NBOMe, and Cimbi-138) is a derivative of the phenethylamine hallucinogen 2C-TFM, discovered by Ralf Heim at the Free University of Berlin by 2000.[1][2] It can be taken to produce psychedelic effects similar to 25I-NBOMe and 25D-NBOMe.[citation needed]

Other namesNBOMe-2C-TFM; 2C-TFM-NBOMe; Cimbi-138
CAS Number
Quick facts Clinical data, Other names ...
25TFM-NBOMe
Clinical data
Other namesNBOMe-2C-TFM; 2C-TFM-NBOMe; Cimbi-138
Drug classSerotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen
Identifiers
  • 2-(4-trifluoromethyl-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H22F3NO3
Molar mass369.384 g·mol−1
3D model (JSmol)
  • FC(F)(F)c1c(OC)cc(c(OC)c1)CCNCc2ccccc2OC
  • InChI=1S/C19H22F3NO3/c1-24-16-7-5-4-6-14(16)12-23-9-8-13-10-18(26-3)15(19(20,21)22)11-17(13)25-2/h4-7,10-11,23H,8-9,12H2,1-3H3 checkY
  • Key:FBHVTQIAHOTPAM-UHFFFAOYSA-N checkY
  (verify)
Close

Interactions

Pharmacology

Pharmacodynamics

More information Target, Affinity (Ki, nM) ...
25TFM-NBOMe activities
TargetAffinity (Ki, nM)
5-HT1AND
5-HT1BND
5-HT1D1,817
5-HT1END
5-HT1FND
5-HT2A0.35–0.49 (Ki)
0.96–2.0 (EC50Tooltip half-maximal effective concentration)
80–92% (EmaxTooltip maximal efficacy)
5-HT2B1.1 (Ki)
ND (EC50)
ND (Emax)
5-HT2C2.7 (Ki) (rat)
11.5 (EC50)
110% (Emax)
5-HT3ND
5-HT4ND
5-HT5A8,128
5-HT623.4
5-HT75,974
α1Aα1DND
α2Aα2CND
β1β3ND
D1D5ND
H1H4ND
M1M5ND
I1ND
σ1, σ2ND
ORsND
TAAR1Tooltip Trace amine-associated receptor 1ND
SERTTooltip Serotonin transporterND (Ki)
ND (IC50Tooltip half-maximal inhibitory concentration)
ND (EC50)
NETTooltip Norepinephrine transporterND (Ki)
ND (IC50)
ND (EC50)
DATTooltip Dopamine transporterND (Ki)
ND (IC50)
ND (EC50)
Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified. Refs: [3][4][5][6]
Close

25TFM-NBOMe acts as a potent partial agonist for the serotonin 5-HT2A receptor, though its relative potency is disputed, with some studies finding it to be of lower potency than 25I-NBOMe,[7][8] while others show it to be of similar or higher potency,[9] possibly because of differences in the assay used.[10]

Chemistry

Analogues

Analogues of 25TFM-NBOMe include 2C-TFM, DOTFM, and TFMFly (DOTFM-FLY), among others.

History

25TFM-NBOMe was first described in the scientific literature by Ralf Heim and colleagues at the Free University of Berlin by 2000.[1][2]

Society and culture

Canada

25TFM-NBOMe is a controlled substance in Canada under phenethylamine blanket-ban language.[11]

United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[12]

See also

References

Related Articles

Timelines

Top Qs

Fact Checks